Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Asset disposition
Appointed director
|
|
CTI BIOPHARMA CORP (CTI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Unknown transaction of 3,989,130 shares
@ $9.1, valued at
$36.3M
Unknown transaction of 2,595,239 shares
@ $9.1, valued at
$23.6M
Unknown transaction of 702,505 shares
@ $9.1, valued at
$6.4M
Unknown transaction of 1,526,147 shares
@ $9.1, valued at
$13.9M
Unknown transaction of 43,139 shares
@ $9.1, valued at
$392.6k
Unknown transaction of 1,594 options to buy
@ $0
Unknown transaction of 1,250 options to buy
@ $0
Unknown transaction of 191 options to buy
@ $0
Unknown transaction of 12 options to buy
@ $0
Unknown transaction of 344 options to buy
@ $0
Unknown transaction of 239 options to buy
@ $0 |
|
| 03/16/2023 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 900,000 options to buy
@ $4.55, valued at
$4.1M
|
|
| 03/16/2023 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 200,000 options to buy
@ $4.55, valued at
$910k
|
|
| 03/16/2023 |
4
| Fong James K (EVP & Chief Commercial Officer) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 200,000 options to buy
@ $4.55, valued at
$910k
|
|
| 01/26/2023 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 83,200 shares
@ $6, valued at
$499.2k
Sold 2,117 shares
@ $6.01, valued at
$12.7k
Exercised 83,200 options to buy
@ $0.8411, valued at
$70k
Exercised 2,117 options to buy
@ $0.8411, valued at
$1.8k
|
|
| 01/26/2023 |
4
| Fong James K (EVP & Chief Commercial Officer) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 100,000 shares
@ $6, valued at
$600k
Granted 288,000 options to buy
@ $0.9489, valued at
$273.3k
Exercised 100,000 options to buy
@ $0.9489, valued at
$94.9k
|
|
| 01/03/2023 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 13,800 shares
@ $6, valued at
$82.8k
Granted 1,579 shares
@ $5.1085, valued at
$8.1k
Sold 12,000 shares
@ $6, valued at
$72k
Sold 700 shares
@ $6.005, valued at
$4.2k
Sold 4,400 shares
@ $6.01, valued at
$26.4k
Sold 84,683 shares
@ $6.0133, valued at
$509.2k
Exercised 13,800 options to buy
@ $0.8411, valued at
$11.6k
Exercised 12,000 options to buy
@ $0.8411, valued at
$10.1k
Exercised 700 options to buy
@ $0.8411, valued at
$588.8
Exercised 4,400 options to buy
@ $0.8411, valued at
$3.7k
Exercised 84,683 options to buy
@ $0.8411, valued at
$71.2k
|
|
| 01/03/2023 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 13,174 shares
@ $6, valued at
$79k
Granted 214 shares
@ $5.1085, valued at
$1.1k
Sold 12,000 shares
@ $6, valued at
$72k
Sold 800 shares
@ $6.005, valued at
$4.8k
Sold 1,047 shares
@ $6.01, valued at
$6.3k
Sold 27,021 shares
@ $6.011, valued at
$162.4k
Exercised 13,174 options to buy
@ $0.9489, valued at
$12.5k
Exercised 12,000 options to buy
@ $0.9489, valued at
$11.4k
Exercised 800 options to buy
@ $0.9489, valued at
$759.1
Exercised 1,047 options to buy
@ $0.9489, valued at
$993.5
Exercised 27,021 options to buy
@ $0.9489, valued at
$25.6k
|
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2022 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 9,516 shares
@ $2.1165, valued at
$20.1k
Sold 22,592 shares
@ $6.02, valued at
$136k
Exercised 22,592 options to buy
@ $0.9489, valued at
$21.4k
|
|
| 09/14/2022 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 242,300 shares
@ $6.43, valued at
$1.6M
Exercised 242,300 options to buy
@ $0.8411, valued at
$203.8k
|
|
| 08/16/2022 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Bought 5,000 shares
@ $5.5, valued at
$27.5k
|
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Metzger Michael A (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 9,000 shares
@ $6.5, valued at
$58.5k
Sold 5,900 shares
@ $6.51, valued at
$38.4k
Sold 3,321 shares
@ $6.52, valued at
$21.7k
Sold 400 shares
@ $6.53, valued at
$2.6k
Sold 400 shares
@ $6.54, valued at
$2.6k
Sold 1,100 shares
@ $6.55, valued at
$7.2k
|
|
| 07/07/2022 |
4
| Metzger Michael A (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 8,700 shares
@ $5.9766, valued at
$52k
Sold 51,963 shares
@ $6.0512, valued at
$314.4k
Sold 27,506 shares
@ $6.1403, valued at
$168.9k
Sold 3,331 shares
@ $6.2255, valued at
$20.7k
Exercised 91,500 options to buy
@ $0.8411, valued at
$77k
|
|
| 07/06/2022 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 6,183 shares
@ $2.1165, valued at
$13.1k
Sold 27,000 shares
@ $6, valued at
$162k
Sold 27,000 shares
@ $6, valued at
$162k
Sold 18,223 shares
@ $6.11, valued at
$111.3k
Exercised 27,000 options to buy
@ $0.8411, valued at
$22.7k
Exercised 27,000 options to buy
@ $0.8411, valued at
$22.7k
Exercised 18,223 options to buy
@ $0.8411, valued at
$15.3k
|
|
| 06/17/2022 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 10,000 shares
@ $6, valued at
$60k
Sold 50,000 shares
@ $6.2501, valued at
$312.5k
Exercised 10,000 options to buy
@ $1, valued at
$10k
Exercised 50,000 options to buy
@ $3.3, valued at
$165k
|
|
| 06/16/2022 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 10,000 shares
@ $5.5, valued at
$55k
Exercised 10,000 options to buy
@ $0.9489, valued at
$9.5k
|
|
| 06/03/2022 |
4/A
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Exercised 27,000 options to buy
@ $0.8411, valued at
$22.7k
Exercised 27,000 options to buy
@ $0.8411, valued at
$22.7k
Exercised 18,223 options to buy
@ $0.8411, valued at
$15.3k
|
|
| 06/03/2022 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 27,000 shares
@ $6, valued at
$162k
Sold 27,000 shares
@ $6, valued at
$162k
Sold 18,223 shares
@ $6.01, valued at
$109.5k
Exercised 27,000 options to buy
@ $0.8411, valued at
$22.7k
Exercised 27,000 options to buy
@ $0.8411, valued at
$22.7k
Exercised 18,223 options to buy
@ $0.8411, valued at
$15.3k
|
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Tuckson Reed Vaughn (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 80,000 options to buy
@ $4.49, valued at
$359.2k
|
|
| 03/11/2022 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 80,000 options to buy
@ $4.49, valued at
$359.2k
|
|
| 03/11/2022 |
4
| Parks Diane L. (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 80,000 options to buy
@ $4.49, valued at
$359.2k
|
|
| 03/11/2022 |
4
| Parkinson David Ross (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 80,000 options to buy
@ $4.49, valued at
$359.2k
|
|
| 03/11/2022 |
4
| Metzger Michael A (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 80,000 options to buy
@ $4.49, valued at
$359.2k
|
|
| 03/11/2022 |
4
| Fischer Laurent (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 80,000 options to buy
@ $4.49, valued at
$359.2k
|
|
| 03/11/2022 |
4
| KIRSKE DAVID (EVP, CFO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 1,782 shares
@ $2.125, valued at
$3.8k
Granted 1,817 shares
@ $2.108, valued at
$3.8k
Granted 280,000 options to buy
@ $4.49, valued at
$1.3M
|
|
| 03/11/2022 |
4
| SEELEY BRUCE J. (EVP, COO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 3,164 shares
@ $2.125, valued at
$6.7k
Granted 3,241 shares
@ $2.108, valued at
$6.8k
Granted 280,000 options to buy
@ $4.49, valued at
$1.3M
|
|
| 03/11/2022 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 3,178 shares
@ $2.108, valued at
$6.7k
Granted 1,115,000 options to buy
@ $4.49, valued at
$5M
|
|
| 03/11/2022 |
3
| Fong James K (See Remarks) has filed a Form 3 on CTI BIOPHARMA CORP |
|
|
|